4Macleod MJ, Mclay J. Drug treatment of hypertension complicating diabetes mellitus [ J ]. Drugs, 1998, 56(2): 189-202.
5Tamasawa N, Matsui J, Ogawa Y, et al. Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension [ J ]. Diabetes Complications, 2000,14(3) :135-139.
6Totsuka M, Miyashita Y, Ito Y, et al. The effect of celiprolol hydrochloride for lipid metabolism-especially for the low density lipoprotein particle size [ J ].Nippon Ronen Igakkai Zasshi, 2001,38(3) :352-359.
7Noguchi N, Nishino K, Niki E. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation[ J ]. Biochem Pharmacol, 2000, 59(9) :1069-1076.
8Pressel S, Davis BR, Louis G T, et al. Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ( ALLHAT) [J]. Control Clin Trials, 2001,22(6): 674-686.
9Ahaneku JE, Sakata K, Urano T, et al. Influence of baseline values on lipids,lipeproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients [ J ]. Pharmacol Res, 2001,41 ( 1 ): 75-79.
10Ashida T. Treatment of hypertension with dyslipidemia [ J ]. Nippon Rinsho,2001,59 (5) :978-982.
8Svensson S, Kjellgren KI. Adverse events and patients' perceptions of antihy pertensive drug effectiveness. Journal of Human Hypertension, 2003; 17(10) :671-5.
9Takishita S. Antihypertensive drug therapy: adverse effects and drug interactions[J]. Nippon Rinsho. 2001,59(5) :992-7.
